Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Yiman Shang"'
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Colorectal cancer (CRC) is the third most prevalent cancer worldwide and poses a serious challenge for clinicians. Previous studies have shown promising results in patients with Microsatellite Stable microsatellite-stable CRC refr
Externí odkaz:
https://doaj.org/article/8f09b5960c4d43e7bcb4c9f54e58d484
Autor:
Baozhen Ma, Yu Zhou, Yiman Shang, Yong Zhang, Benling Xu, Xiaomin Fu, Jindong Guo, Yonghao Yang, Fang Zhang, Mengyuan Zhou, Hao Huang, Fanghui Li, Hongwei Lin, Lingdi Zhao, Zibing Wang, Quanli Gao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Despite recent progress in treating advanced non-small cell lung cancer, clinical intervention in extensive-stage small-cell lung cancer (ES-SCLC) remains stagnant. The purpose of this study was to evaluate the clinical efficacy of cytokine-induced k
Externí odkaz:
https://doaj.org/article/fa0f124aa8244db3847402348736cf72
Autor:
Lingdi Zhao, Tiepeng Li, Yongping Song, Yonghao Yang, Baozhen Ma, Yong Zhang, Yiman Shang, Benling Xu, Jindong Guo, Peng Qin, Lu Han, Xiaomin Fu, Hongwei Lin, Liang Liu, Xiubao Ren, Zibing Wang, Quanli Gao
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Background and ObjectiveThe results of the CheckMate 025 trial established the status of nivolumab in the second-line treatment of metastatic renal cell carcinoma (mRCC), with an objective response rate (ORR) of 25% and a complete response (CR) rate
Externí odkaz:
https://doaj.org/article/243413ee34b54048850fc83d50d4b9e3
Autor:
Wenqun Xing, Lingdi Zhao, Yan Zheng, Baoxing Liu, Xianben Liu, Tiepeng Li, Yong Zhang, Baozhen Ma, Yonghao Yang, Yiman Shang, Xiaomin Fu, Guanghui Liang, Dongfeng Yuan, Jinrong Qu, Xiaofei Chai, He Zhang, Zibing Wang, Hongwei Lin, Liang Liu, Xiubao Ren, Jiangong Zhang, Quanli Gao
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThere is no standard neoadjuvant therapy for locally advanced esophageal cancer in China. The role of neoadjuvant chemotherapy plus immunotherapy for locally advanced esophageal cancer is still being explored.MethodsThis open-label, randomi
Externí odkaz:
https://doaj.org/article/00334cde9e1b4ce68205dfd247332859
Autor:
Xiaomin Fu, Xiaoyan Zhu, Fujun Qin, Yong Zhang, Jizhen Lin, Yuechao Ding, Zihe Yang, Yiman Shang, Li Wang, Qinxian Zhang, Quanli Gao
Publikováno v:
Molecular Cancer, Vol 21, Iss 1, Pp 1-1 (2022)
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12943-018-0783-3.
Externí odkaz:
https://doaj.org/article/56cd01f62e264167a9a23fe12e463c7d
Autor:
Xiaomin Fu, Xiaoyan Zhu, Fujun Qin, Yong Zhang, Jizhen Lin, Yuechao Ding, Zihe Yang, Yiman Shang, Li Wang, Qinxian Zhang, Quanli Gao
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-14 (2018)
Abstract Background Liver tumor initiating cells (TICs) have self-renewal and differentiation properties, accounting for tumor initiation, metastasis and drug resistance. Long noncoding RNAs are involved in many physiological and pathological process
Externí odkaz:
https://doaj.org/article/0d90261b2d084ef1b28a4beb733f5c5d
Autor:
Zibing Wang, Yuqing Liu, Rui’e Li, Yiman Shang, Yong Zhang, Lingdi Zhao, Wei Li, Yonghao Yang, Xiaojie Zhang, Tiejun Yang, Changfu Nie, Feng Han, Ying Liu, Suxia Luo, Quanli Gao, Yongping Song
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-7 (2016)
Abstract Background Advanced pancreatic cancer (PC) has very poor prognosis with present treatments, thus necessitating continued efforts to find improved therapeutic approaches. Both preclinical and preliminary clinical data indicate that cytokine-i
Externí odkaz:
https://doaj.org/article/f86eb50b38a54d46b8c58cdbe8409222
Autor:
Quanli Gao, Shengdian Wang, Hongle Li, Zhichao Tian, Zhiyong Liu, Yan Ma, Chaojie Feng, Dongfeng Yuan, Kai Zhang, Qingjun Li, Yiman Shang, Fang Zhang, Baozhen Ma, Benling Xu, Peng Qin, Guangyu Chen, Jindong Guo, Yong Zhang, Yao Wang, Yonghao Yang, Lingdi Zhao, Tiepeng Li
Information on previous treatment of patients included in the observational study.LTIL-01.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127374600f3bc19ced36ce064906df92
https://doi.org/10.1158/0008-5472.22430001.v1
https://doi.org/10.1158/0008-5472.22430001.v1
Autor:
Quanli Gao, Shengdian Wang, Hongle Li, Zhichao Tian, Zhiyong Liu, Yan Ma, Chaojie Feng, Dongfeng Yuan, Kai Zhang, Qingjun Li, Yiman Shang, Fang Zhang, Baozhen Ma, Benling Xu, Peng Qin, Guangyu Chen, Jindong Guo, Yong Zhang, Yao Wang, Yonghao Yang, Lingdi Zhao, Tiepeng Li
Additional information on patients included in Figure 1-5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21544703108da0ea0bec1bd1741aa7a4
https://doi.org/10.1158/0008-5472.22429974.v1
https://doi.org/10.1158/0008-5472.22429974.v1
Autor:
Quanli Gao, Shengdian Wang, Hongle Li, Zhichao Tian, Zhiyong Liu, Yan Ma, Chaojie Feng, Dongfeng Yuan, Kai Zhang, Qingjun Li, Yiman Shang, Fang Zhang, Baozhen Ma, Benling Xu, Peng Qin, Guangyu Chen, Jindong Guo, Yong Zhang, Yao Wang, Yonghao Yang, Lingdi Zhao, Tiepeng Li
Both tumor-infiltrating lymphocytes (TIL) and PD-1+ peripheral blood lymphocytes (PBL) are enriched for tumor-reactive clones recognizing known and unknown tumor antigens. However, the relationship between the T-cell receptor-β (TCRβ) repertoires o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de1a5429ca181b7c6c3355d612947af
https://doi.org/10.1158/0008-5472.c.6513504
https://doi.org/10.1158/0008-5472.c.6513504